Documents & Downloads

Pertuzumab zuvotolimod

HER2 ADC

Pertuzumab zuvotolimod is an anti-HER2 antibody-drug conjugate (ADC) designed to target HER2-positive tumors. The combination of a humanized anti-HER2 antibody, Pertuzumab, with a TLR8 agonist payload and a linker enhances anti-tumor immune responses by activating myeloid cells and inducing T and NK cell cytolytic activity. This reagent is suitable for research focused on HER2-expressing solid tumors, providing a valuable tool for studying therapeutic strategies in this area.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
Actions	Agonist
CAS Number	2500674-05-3
Applications	HER2 ADC
Synonyms	SBT6050

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.